Kanagawa Cancer Center - Dept of Respiratory Medicine

Yokohama

0 studies enrolling now · 2 studies all time

What they study most

Non-small Cell Lung Cancer

Studies at this site

• A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2) — Running, not enrolling
• M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) — Stopped early